Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Lenalidomide
×
Plasma cell
×
Clear all
Filters
3
NCT01953692
2021-08-04
MK-3475-013
Merck Sharp & Dohme LLC
Phase 1
Completed
197 enrolled
52 charts
NCT01742793
2020-03-04
RID
Yale University
Phase 1
Terminated
12 enrolled